Patents by Inventor Philippe Goffin
Philippe Goffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10696997Abstract: A cassette sequence for the transformation of a host cell includes at least: a first nucleotide sequence encoding a peptide or protein of interest to be produced by the host cell. The first sequence is linked to a second nucleotide sequence providing resistance to a toxin or encoding an antitoxin peptide to the toxin. The nucleotide sequences are organized in such a way that production of the peptide encoded by the second nucleotide sequence(s) is translationally coupled to production of the peptide encoded by the first nucleotide sequence.Type: GrantFiled: July 6, 2015Date of Patent: June 30, 2020Assignee: UNIVERSITE LIBRE DE BRUXELLESInventors: Laurence Van Melderen, Baptiste J. S. Dumont, Thibaut Hallaert, Gilles Vanwalleghem, Philippe Goffin
-
Publication number: 20190322708Abstract: Methods for the production of a bacterial toxin such as diphtheria toxin, and methods for producing conjugates of a bacterial toxins, are provided.Type: ApplicationFiled: July 11, 2019Publication date: October 24, 2019Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
-
Publication number: 20180258146Abstract: Methods for producing a conjugate of a bacterial toxin, including diphtheria toxin or CRM197, are provided.Type: ApplicationFiled: May 8, 2018Publication date: September 13, 2018Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Normand BLAIS, Philippe Marc Helene DEHOTTAY, Marianne DEWERCHIN, Philippe GOFFIN, Denis MARTIN
-
Patent number: 9994622Abstract: Compositions and methods related to periplasmic expression of a toxin including diphtheria toxin or CRM197 are provided herein.Type: GrantFiled: July 14, 2016Date of Patent: June 12, 2018Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
-
Publication number: 20170314053Abstract: A cassette sequence for the transformation of a host cell includes at least: a first nucleotide sequence encoding a peptide or protein of interest to be produced by the host cell. The first sequence is linked to a second nucleotide sequence providing resistance to a toxin or encoding an antitoxin peptide to the toxin. The nucleotide sequences are organized in such a way that production of the peptide encoded by the second nucleotide sequence(s) is translationally coupled to production of the peptide encoded by the first nucleotide sequence.Type: ApplicationFiled: July 6, 2015Publication date: November 2, 2017Applicant: UNIVERSITE LIBRE DE BRUXELLESInventors: Laurence VAN MELDEREN, Baptiste J. S. DUMONT, Thibaut HALLAERT, Gilles VANWALLEGHEM, Philippe GOFFIN
-
Patent number: 9765294Abstract: Chemically defined media for the industrial-scale culture of Bordetella species.Type: GrantFiled: September 11, 2014Date of Patent: September 19, 2017Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Philippe Marc Helene Dehottay, Philippe Goffin, Filipe Branco dos Santos, Bas Teusink
-
Publication number: 20170137475Abstract: Compositions and methods related to periplasmic expression of a toxin including diphtheria toxin or CRM197 are provided herein.Type: ApplicationFiled: July 14, 2016Publication date: May 18, 2017Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Normand BLAIS, Philippe Marc Helene DEHOTTAY, Marianne DEWERCHIN, Philippe GOFFIN, Denis MARTIN
-
Publication number: 20160378909Abstract: Methods for identifying culture conditions for a cell, the method comprising: (a) obtaining a genome scale stoichiometric metabolic model of the cell, and (b) performing constraint based optimization on the metabolic model of the cell using at least one yield based constraint.Type: ApplicationFiled: December 15, 2014Publication date: December 29, 2016Applicant: GLAXOSMITHKLINE BIOLOGICALS SAInventors: Philippe Marc Helene DEHOTTAY, Philippe GOFFIN, Bas TEUSINK, Filipe BRANCO DOS SANTOS
-
Patent number: 9475848Abstract: A process for fermenting Bordetella species comprising incubating a sample of bacteria of a Bordetella species in a first environment under at least one bvg (Bordetella virulence genes) modulating condition, for at least 5 generations, to produce a mature culture, and then incubating the mature culture in a second environment in the absence of the at least one bvg modulating condition.Type: GrantFiled: January 30, 2013Date of Patent: October 25, 2016Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
-
Patent number: 9422345Abstract: Polynucleotides are provided herein.Type: GrantFiled: October 7, 2010Date of Patent: August 23, 2016Assignee: GlaxoSmithKline Biologicals S.A.Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin
-
Publication number: 20160222344Abstract: Chemically defined media for the industrial-scale culture of Bordetella species.Type: ApplicationFiled: September 11, 2014Publication date: August 4, 2016Inventors: Philippe Marc Helene DEHOTTAY, Philippe GOFFIN, Filipe Branco dos Santos, Bas TEUSINK
-
Patent number: 9346861Abstract: The present invention provides a process for periplasmic expression of a bacterial toxoid comprising the steps of: a) growing a culture of a gram negative host cell in a fermentation medium, wherein the host cell is transformed with a polynucleotide, and wherein the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence; or providing a gram negative host cell wherein the host cell is transformed with a polynucleotide, the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence and wherein the gram negative host cell comprises the bacterial toxoid expressed in the periplasm; a(i)) inducing expression of the bacterial toxoid; b) maturing the host cell, wherein the maturing step comprises: I) subjecting the host cell to a pH shock; II) incubating the host cell with no feed addition; and/or III) subjecting the host cell to a temperature below ?20° C.; and c) extracting the bacterial toxoid from the host cell wherein the extraction process comprises osmotic shock.Type: GrantFiled: April 12, 2012Date of Patent: May 24, 2016Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
-
Publication number: 20150010948Abstract: A process for fermenting Bordetella species comprising incubating a sample of bacteria of a Bordetella species in a first environment under at least one bvg (Bordetella virulence genes) modulating condition, for at least 5 generations, to produce a mature culture, and then incubating the mature culture in a second environment in the absence of the at least one bvg modulating condition.Type: ApplicationFiled: January 30, 2013Publication date: January 8, 2015Inventors: Philippe Marc Helene Dehottay, Philippe Goffin
-
Publication number: 20140050758Abstract: The present invention provides a process for periplasmic expression of a bacterial toxoid comprising the steps of: a), growing a culture of a gram negative host cell in a fermentation medium, wherein the host cell is transformed with a polynucleotide, and wherein the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence; or providing a gram negative host cell wherein the host cell is transformed with a polynucleotide, the polynucleotide encodes the bacterial toxoid and a periplasmic signal sequence and wherein the gram negative host cell comprises the bacterial toxoid expressed in the periplasm; a(i)) inducing expression of the bacterial toxoid; b) maturing the host ceil, wherein the maturing step comprises; I) subjecting the host cell to a pH shock; II) incubating the host ceil with no feed addition; and/or III) subjecting the host ceil to a temperature below ?20° C.; and c) extracting the bacterial toxoid from the host cell wherein the extraction process comprises osmotic shock.Type: ApplicationFiled: April 12, 2012Publication date: February 20, 2014Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.Inventors: Philippe Marc Helene Dohottay, Philippe Goffin
-
Publication number: 20120289688Abstract: Polynucleotides are provided herein.Type: ApplicationFiled: October 7, 2010Publication date: November 15, 2012Inventors: Normand Blais, Philippe Marc Helene Dehottay, Marianne Dewerchin, Philippe Goffin, Denis Martin